Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma.

Klinac, Dragana; Gray, Elin S; Freeman, James B; Reid, Anna; Bowyer, Samantha; Millward, Michael; Ziman, Melanie

Klinac, Dragana; Gray, Elin S; Freeman, James B; Reid, Anna; Bowyer, Samantha; Millward, Michael; Ziman, Melanie.

Affiliation

Gray ES; School of Medical Sciences, Edith Cowan University (ECU), 270 Joondalup Drive, Joondalup, Perth, WA 6027, Australia. e.gray@ecu.edu.au.

BMC Cancer ; 14: 423, 2014 Jun 11.

Article in En | MEDLINE | ID: mdl-24915896

Subject(s)

Melanoma/blood; Neoplastic Cells, Circulating; Prognosis; Skin Neoplasms/blood; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor/blood; Disease-Free Survival; Female; Humans; Indoles/administration & dosage; Male; Melanoma/drug therapy; Melanoma/pathology; Middle Aged; Skin Neoplasms/drug therapy; Skin Neoplasms/pathology; Sulfonamides/administration & dosage; Treatment Outcome; Vemurafenib

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prognosis / Skin Neoplasms / Melanoma / Neoplastic Cells, Circulating Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google